Compare SAIA & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SAIA | BIO |
|---|---|---|
| Founded | 1924 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.4B | 10.1B |
| IPO Year | 2002 | 1994 |
| Metric | SAIA | BIO |
|---|---|---|
| Price | $344.41 | $357.71 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 21 | 3 |
| Target Price | ★ $434.38 | $328.33 |
| AVG Volume (30 Days) | ★ 283.4K | 230.5K |
| Earning Date | 10-29-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 142.61 |
| EPS | ★ 5.37 | N/A |
| Revenue | ★ $3,234,286,000.00 | $2,583,200,000.00 |
| Revenue This Year | $11.65 | N/A |
| Revenue Next Year | $7.45 | $2.47 |
| P/E Ratio | $62.86 | ★ N/A |
| Revenue Growth | ★ 0.79 | 0.65 |
| 52 Week Low | $249.32 | $236.73 |
| 52 Week High | $494.71 | $396.23 |
| Indicator | SAIA | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 38.21 | 48.40 |
| Support Level | $308.92 | $364.41 |
| Resistance Level | $345.84 | $392.81 |
| Average True Range (ATR) | 10.45 | 9.33 |
| MACD | -0.21 | -1.87 |
| Stochastic Oscillator | 18.02 | 33.74 |
Saia ranks among the 10 largest less-than-truckload carriers in the United States, with more than 210 facilities and a fleet of more than 7,500 tractors and 26,000 trailers. As a national LTL carrier, the firm offers time-definite and expedited options for shipments ranging between 100 and 10,000 pounds. Saia ranks among the top-tier providers in terms of profitability.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.